Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Cash from Financing Activities (2018 - 2026)

Health Catalyst filings provide 9 years of Cash from Financing Activities readings, the most recent being -$4000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 99.92% to -$4000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$231.1 million, a 258.08% decrease, with the full-year FY2025 number at -$235.8 million, down 255.38% from a year prior.
  • Cash from Financing Activities hit -$4000.0 in Q1 2026 for Health Catalyst, up from -$434000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $112.5 million in Q3 2024 to a low of -$230.1 million in Q2 2025.
  • Median Cash from Financing Activities over the past 5 years was $637000.0 (2022), compared with a mean of -$4.9 million.
  • Biggest five-year swings in Cash from Financing Activities: soared 10716.83% in 2024 and later plummeted 33065.47% in 2025.
  • Health Catalyst's Cash from Financing Activities stood at $637000.0 in 2022, then crashed by 37.99% to $395000.0 in 2023, then skyrocketed by 9441.77% to $37.7 million in 2024, then tumbled by 101.15% to -$434000.0 in 2025, then skyrocketed by 99.08% to -$4000.0 in 2026.
  • The last three reported values for Cash from Financing Activities were -$4000.0 (Q1 2026), -$434000.0 (Q4 2025), and -$537000.0 (Q3 2025) per Business Quant data.